Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.
Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.
复制标题
DOI:
10.1016/j.neurobiolaging.2014.07.037
复制
发表时间:
2015-01
影响因子:
4.2
通讯作者:
Fisher EM
中科院分区:
文献类型:
--
作者:
Fratta P;Polke JM;Newcombe J;Mizielinska S;Lashley T;Poulter M;Beck J;Preza E;Devoy A;Sidle K;Howard R;Malaspina A;Orrell RW;Clarke J;Lu CH;Mok K;Collins T;Shoaii M;Nanji T;Wray S;Adamson G;Pittman A;Renton AE;Traynor BJ;Sweeney MG;Revesz T;Houlden H;Mead S;Isaacs AM;Fisher EM
An expanded hexanucleotide repeat in the C9orf72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Although 0–30 hexanucleotide repeats are present in the general population, expansions >500 repeats are associated with C9ALS/FTD. Large C9ALS/FTD expansions share a common haplotype and whether these expansions derive from a single founder or occur more frequently on a predisposing haplotype is yet to be determined and is relevant to disease pathomechanisms. Furthermore, although cases carrying 50–200 repeats have been described, their role and the pathogenic threshold of the expansions remain to be identified and carry importance for diagnostics and genetic counseling. We present clinical and genetic data from a UK ALS cohort and report the detailed molecular study of an atypical somatically unstable expansion of 90 repeats. Our results across different tissues provide evidence for the pathogenicity of this repeat number by showing they can somatically expand in the central nervous system to the well characterized pathogenic range. Our results support the occurrence of multiple expansion events for C9ALS/FTD.
登录
查看更多内容
影响因子:
3.7
作者:
Dobson-Stone C;Hallupp M;Loy CT;Thompson EM;Haan E;Sue CM;Panegyres PK;Razquin C;Seijo-Martínez M;Rene R;Gascon J;Campdelacreu J;Schmoll B;Volk AE;Brooks WS;Schofield PR;Pastor P;Kwok JB
通讯作者:
Kwok JB
DOI:
10.1016/s1474-4422(12)70043-1
发表时间:
2012-04
期刊:
The Lancet. Neurology
影响因子:
--
作者:
Majounie E;Renton AE;Mok K;Dopper EG;Waite A;Rollinson S;Chiò A;Restagno G;Nicolaou N;Simon-Sanchez J;van Swieten JC;Abramzon Y;Johnson JO;Sendtner M;Pamphlett R;Orrell RW;Mead S;Sidle KC;Houlden H;Rohrer JD;Morrison KE;Pall H;Talbot K;Ansorge O;Chromosome 9-ALS/FTD Consortium;French research network on FTLD/FTLD/ALS;ITALSGEN Consortium;Hernandez DG;Arepalli S;Sabatelli M;Mora G;Corbo M;Giannini F;Calvo A;Englund E;Borghero G;Floris GL;Remes AM;Laaksovirta H;McCluskey L;Trojanowski JQ;Van Deerlin VM;Schellenberg GD;Nalls MA;Drory VE;Lu CS;Yeh TH;Ishiura H;Takahashi Y;Tsuji S;Le Ber I;Brice A;Drepper C;Williams N;Kirby J;Shaw P;Hardy J;Tienari PJ;Heutink P;Morris HR;Pickering-Brown S;Traynor BJ
通讯作者:
Traynor BJ
影响因子:
3.5
作者:
Dols-Icardo, Oriol;Garcia-Redondo, Alberto;Clarimon, Jordi
通讯作者:
Clarimon, Jordi
影响因子:
9.9
作者:
van Blitterswijk, Marka;Baker, Matthew C.;Rademakers, Rosa
通讯作者:
Rademakers, Rosa
影响因子:
9.9
作者:
Moss, Davina J. Hensman;Poulter, Mark;Tabrizi, Sarah J.
通讯作者:
Tabrizi, Sarah J.